Sunpointe’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Buy
8,919
+663
+8% +$148K 0.62% 38
2025
Q4
$1.42M Buy
8,256
+43
+0.5% +$6.69K 0.47% 45
2025
Q3
$1.1M Sell
8,213
-34
-0.4% -$3.6K 0.4% 54
2025
Q2
$805K Sell
8,247
-722
-8% -$57.3K 0.32% 70
2025
Q1
$654K Sell
8,969
-55
-0.6% -$4.33K 0.35% 63
2024
Q4
$654K Sell
9,024
-376
-4% -$28.5K 0.33% 67
2024
Q3
$770K Buy
9,400
+90
+1% +$7.83K 0.63% 37
2024
Q2
$994K Buy
9,310
+160
+2% +$15.3K 0.65% 32
2024
Q1
$891K Buy
9,150
+10
+0.1% +$880 0.99% 24
2023
Q4
$718K Buy
+9,140
New +$623K 0.91% 26

Other funds holding LRCX

Sunpointe's LRCX Position: Q1 2026 in Review

Sunpointe increased its Lam Research (LRCX) stake by 8% in Q1 2026, buying an estimated $148K and bringing the position to 8,919 shares worth $1.91M. The position accounts for 0.62% of the portfolio, ranked #38.

Sunpointe first reported a position in LRCX in Q4 2023 and has held it in 10 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Sunpointe held 8,919 shares of Lam Research worth $1.91M as of Q1 2026.
  • Sunpointe bought 663 Lam Research shares in Q1 2026, an estimated $148K.
  • Lam Research made up 0.62% of Sunpointe's portfolio in Q1 2026, its #38 holding.
  • Sunpointe first reported a position in Lam Research in Q4 2023 and has held it in 10 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Sunpointe's 13F filing for Q1 2026, filed 21 Apr 2026.